Can you tell me about Piramal acquiring Yapan Bio and its purpose?
Answer
Answer
Piramal Pharma, a unit of Piramal Enterprises Ltd or PEL, announced the acquisition of 27.78% stake in Yapan Bio, a contract process development and manufacturing organization (CDMO) company. This unit is based out of the Genome valley in Hyderabad. The total stake buy is valued at Rs.102 crore. Yapan Bio focusses on biologics, which is currently the fastest growing segment within CDMO.